ZFP36 and Hepatic fibrosis: Sorafenib and erastin, two ferroptosis inducers, markedly reduce hepatic fibrosis in mice subjected to a bile duct ligation and the overexpression of TTP in HSCs (through vitamin A-coupled liposomes bearing Zfp36 plasmid) strongly reduces this beneficial effect.